Cover Image
Evolution Global Talent Attraction

Evolution Global Talent Attraction

11 followers

11-50 employees

Evolution Global Talent Attraction
Evolution Global Talent Attractionposted this article6 February 2019
We analysed 200+ active FDA Clinical Trials to highlight the Viral Vectors and Cell Lines most in demand. We then examine the key players involved and explored how the biomanufacturing industry is adapting and innovating. View our full Data Visualisation here: http://bit.ly/CGTexec

Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment

Cell and gene therapies (CGTs) offer an unprecedented opportunity to treat diseases for which existing interventions are inadequate, potentially offering cures for previously terminal illnesses. However, several challenges have arisen for CGT developers and manufacturing partners due to the complex and time consuming processes involved. One of the primary manufacturing challenges currently bottlenecking the industry is the increasing demand for viral vectors.https://evolutionexec.com/news-analysis/cell-gene-therapies-increasing-demand-for-viral-vectors-drives-biomanufacturing-innovation-cdmo-investment/
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
Evolution Global Talent Attraction
Evolution Global Talent Attractionposted this article15 January 2019
2018 Global Drug Development IPO Review: $10.24B raised by 95 companies in strongest year on record: http://bit.ly/2018IPO - BeiGene eclipses Moderna Therapeutics for largest IPO - APAC markets ease regulations for pre-profit biotech companies - Oncology-focused companies raise $6.3B - Gene Therapy companies raise $1.22B for best year on record

2018 Global Drug Development IPO Analysis: $10.24B Raised in Strongest Year on Record

The Drug Development IPO market enjoyed a strong year in 2018, with over $10.24B raised by 95 companies across 15 global exchanges. When compared to 2017, this marks a 28% increase in the frequency of IPOs and a 41% increase in the total amount f money raised. The results represent a significant surpassing of 2015, which was the best prior year on record. https://evolutionexec.com/news-analysis/2018-global-drug-development-ipo-analysis-over-10b-raised-strongest-year-on-record/
2018 Global Drug Development IPO Analysis: $10.24B Raised in Strongest Year on Record
Evolution Global Talent Attraction
Evolution Global Talent Attractionposted this article8 January 2019
NEW VACANCY: Managing Director of the Medical Technologies Innovation Facility at Nottingham Trent University. APPLY HERE: http://bit.ly/evo1735

Managing Director (Medical Technologies Innovation Facility) [Nottingham Trent University]

We are currently seeking qualified candidates for a Managing Director role with Nottingham Trent University’s Medical Technologies Innovation Facility. This is a permanent position that will be based out of brand new facilities in Nottingham, United Kingdom.https://evolutionexec.com/job/managing-director-medical-technologies-innovation-facility-nottingham-trent-university/
Managing Director (Medical Technologies Innovation Facility) [Nottingham Trent University]

Evolution Executive Search understand the value of people to the continued success of an organisation. Talent sourcing, acquisition and retention are vital to the growth of a company, and as such the market for impact resources within the bio-industries is extremely competitive. We provide elite executive search &...

Discover more about us

Jobs

There aren't any vacancies available right now.

Looking for a job? Check out our recommendations.

Location

Open map

Glasgow

183 Bath Street, G24HU Glasgow, United Kingdom